Effects of MEDI0382, a glucagon-like peptide 1/glucagon receptor dual agonist, on pancreatic and incretin hormones

被引：0
|
作者：
Jermutus, L. [1 ]
Tsai, L. -F. [2 ]
Robertson, D. [1 ]
Petrone, M. [1 ]
Rondinone, C. [2 ]
Boaz, H. [2 ]
Ambery, P. [1 ]
Parker, V. [1 ]
机构：
[1] MedImmune, Cambridge, England
[2] MedImmune, Gaithersburg, MD USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
778
引用
收藏
页码：S382 / S382
页数：1
相关论文
共 50 条
  • [31] Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
    Pocai, Alessandro
    Carrington, Paul E.
    Adams, Jennifer R.
    Wright, Michael
    Eiermann, George
    Zhu, Lan
    Du, Xiaobing
    Petrov, Aleksandr
    Lassman, Michael E.
    Jiang, Guoqiang
    Liu, Franklin
    Miller, Corey
    Tota, Laurie M.
    Zhou, Gaochao
    Zhang, Xiaoping
    Sountis, Michael M.
    Santoprete, Alessia
    Capito, Elena
    Chicchi, Gary G.
    Thornberry, Nancy
    Bianchi, Elisabetta
    Pessi, Antonello
    Marsh, Donald J.
    SinhaRoy, Ranabir
    DIABETES, 2009, 58 (10) : 2258 - 2266
  • [32] MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity: Safety Study in Subjects of Japanese and Chinese Descent
    Robertson, Darren
    Petrone, Marcella
    Tsai, Lan-Feng
    Gasser, Robert A., Jr.
    DIABETES, 2019, 68
  • [33] Phase I Study of Glucagon-like Peptide-1/Glucagon Receptor Dual Agonist BI 456906 in Obesity
    Arrubla, Jorge
    Schoelch, Corinna
    Plum-Moerschel, Leona
    Kapitza, Christoph
    Lamers, Daniela
    Thamer, Claus
    Hennige, Anita M.
    OBESITY, 2021, 29 : 139 - 140
  • [34] GLUCAGON-LIKE PEPTIDE-1 IS A PHYSIOLOGICAL INCRETIN IN RAT
    WANG, ZL
    WANG, RM
    OWJI, AA
    SMITH, DM
    GHATEI, MA
    BLOOM, SR
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01): : 417 - 421
  • [35] Glucagon-like Peptide 1 Receptor Agonist: Balancing Alarm and Caution
    Ziemssen, Focke
    Hammes, Hans-Peter
    Helbig, Horst
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2024, 241 (09) : 1021 - 1022
  • [36] Glucagon-Like Peptide 1 Receptor Agonist Use Before Surgery
    Jones, Philip M.
    Hobai, Ion A.
    JAMA SURGERY, 2024, 159 (09) : 1092 - 1093
  • [37] Continuous Glucose Monitoring Reveals Comprehensive Glucose Control with MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity
    Parker, Victoria E. R.
    Robertson, Darren
    Wang, Tao
    Hornigold, David C.
    Posch, Maximilian G.
    Heise, Tim
    Plum-Moerschel, Leona
    Meier, Juris J.
    Schlichthaar, Heike
    Klaus, Beate M.
    Ambery, Philip
    Hirshberg, Boaz
    DIABETES, 2019, 68
  • [38] Metabolic Effects and Efficacy of Glucagon-like Peptide 1 Receptor Agonist in a Veteran Population
    Kyu, Daisy
    Kawamoto, Jenna
    Meyer, Madison
    Klomhaus, Alexandra
    Romanova, Maria
    Siagian, Cleopatra
    OBESITY, 2023, 31 : 85 - 85
  • [39] Effects of glucagon-like peptide 1 and its receptor agonist - liraglutide on cardiovascular system
    Gajos, Grzegorz
    Stefanski, Adam
    Gumprecht, Janusz
    KARDIOLOGIA POLSKA, 2011, 69 (07) : 709 - 716
  • [40] Glucagon-Like Peptide 1 Analogs and their Effects on Pancreatic Islets
    Tuduri, Eva
    Lopez, Miguel
    Dieguez, Carlos
    Nadal, Angel
    Nogueiras, Ruben
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2016, 27 (05): : 304 - 318
12345